- 积分
- 42
- 威望
- 42
- 包包
- 486
|
本帖最后由 aaaszw 于 2016-12-9 09:16 编辑 6 B `" R: K0 ^ f, Z
# j" L4 Q( v( v7 ?5 r, \
Tumor Interferon Signaling Regulates a Multigenic Resistance Program to Immune Checkpoint Blockade.
8 M2 {3 j7 `' G4 Zhttps://www.ncbi.nlm.nih.gov/pubmed/27912061
# M, X$ D! N; k2 x, S/ a t
- b/ k- G4 H" n5 r2 D9 ]6 G* kThe long non-coding RNA Morrbid regulates Bim and short-lived myeloid cell lifespan.+ W1 J% p: l! g5 h, K& a
https://www.ncbi.nlm.nih.gov/pubmed/27525555
4 @ R$ P- I" i6 ~
& O2 P* y- U. ^, f0 qBioenergetic Insufficiencies Due to Metabolic Alterations Regulated by the Inhibitory Receptor PD-1 Are an Early Driver of CD8(+) T Cell Exhaustion9 U9 _5 F/ A' M( n0 s+ V; ^
https://www.ncbi.nlm.nih.gov/pubmed/27496729
* H6 c5 b8 D' ^3 J# u) z3 f! E% A# P6 W
Cutting Edge: B Cell-Intrinsic T-bet Expression Is Required To Control Chronic Viral Infection.
* k& r$ Y6 W2 p0 Y ~2 ghttps://www.ncbi.nlm.nih.gov/pubmed/27430722+ ~# |7 g5 g. p& G
# X$ ~2 }# T2 f* e) i8 {' Q
Costimulatory and Coinhibitory Receptor Pathways in Infectious Disease., t5 D) l* z, m& [, u) g+ [
https://www.ncbi.nlm.nih.gov/pubmed/27192569
& x# K1 j2 I" ], Z
" `5 v( N5 }" pCombination Cancer Therapies with Immune Checkpoint Blockade: Convergence on Interferon Signaling
# [: j( a: B, {+ D+ Chttps://www.ncbi.nlm.nih.gov/pubmed/27058661; j1 i; R" J3 N3 j/ l
' d( i5 L6 I: j( S" I3 N
De-Risking Immunotherapy: Report of a Consensus Workshop of the Cancer Immunotherapy Consortium of the Cancer Research Institute
! Z* J- z( j2 nhttps://www.ncbi.nlm.nih.gov/pubmed/27036972 |
|